Revenue
No reported data
Ocean Biomedical, Inc. (OCEA)
Price—Loading quote
Net income
2022
2023
2024
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Research & development | $26,000 | $709,000 | $8.4M |
| Operating expenses | $3.8M | $10.2M | $16.1M |
| Operating income | −$3.8M | −$10.2M | −$16.1M |
| Net income | −$9.5M | −$114.5M | −$17.4M |
| Basic EPSper diluted share | -$0.34 | -$4.35 | -$0.74 |
| Diluted EPSper diluted share | -$0.34 | -$4.35 | -$0.74 |